SMFM Statement on Rise in Measles Cases and U.S. Losing Measles-Elimination Status

News,

The Society for Maternal-Fetal Medicine (SMFM) and its members are alarmed by the recent report in The New England Journal of Medicine Evidence showing that there were 112 cases of confirmed measles during pregnancy and 13 cases of congenital measles reported to the U.S. Centers for Disease Control and Prevention (CDC) between January 1, 2025, and September 28, 2026. We are also deeply troubled that the U.S. has lost its measles-elimination status by the Pan American Health Organization after 26 years.

“As high-risk pregnancy experts, we know that receiving the measles-mumps-rubella (MMR) vaccine before pregnancy is proven to be safe and effective in preventing measles,” said Brenna L. Hughes, MD, MSc, chair of the SMFM Committee on Infectious Diseases and Emerging Threats. “We also know how utterly devastating vaccine-preventable infections like measles are for pregnant women, their infants, and their families.”

Although live vaccines, such as MMR, are not recommended during pregnancy, unvaccinated or inadequately vaccinated women should ideally be vaccinated before pregnancy or defer vaccination until after delivery. The MMR vaccine can be administered any time after delivery and is safe to receive while breastfeeding.

Losing measles-elimination status means that the U.S. has had twelve months or more of uncontrolled transmission of the virus. Since January 2025, the U.S. has had over 7,700 reported measles cases continuously throughout several states. Nearly all of the reported cases during pregnancy since 2025 were among those who had not received the MMR vaccine before pregnancy or had unknown vaccination status.

Measles is a preventable disease that can lead to severe maternal, fetal, and infant illness. Pregnant people are at an increased risk of hospitalization, pneumonia, need for oxygen support or mechanical ventilation, and death. Fetal and neonatal risks include an increased risk of miscarriage, stillbirth, low birth weight, prematurity, and infant death.

“The CDC numbers illustrate how important it is that we focus our efforts on restoring public health funding and staffing for vaccination efforts at the federal, state, and local levels. It is equally important for trusted clinicians who care for women who may be pregnant or become pregnant to provide evidence-based guidance about the importance of being vaccinated before pregnancy,” said Dr. Hughes.

The resurgence of measles and the loss of elimination status could have been avoided. Still, SMFM is cautiously optimistic about the commitment described in the December 17 CDC joint statement to stop measles outbreaks, protect people, and regain measles elimination status.

For more information:


#  #  #

 

About SMFM         
The Society for Maternal-Fetal Medicine (SMFM), founded in 1977, is the medical professional society for obstetricians who have additional training in high-risk, complicated pregnancies. SMFM represents more than 6,500 members who care for high-risk pregnant people and provides education, promotes research, and engages in advocacy to reduce disparities and optimize the health of high-risk pregnant people and their families. SMFM and its members are dedicated to optimizing maternal and fetal outcomes and assuring medically appropriate treatment options are available to all patients. www.smfm.org  

Media Contact:  Greg Phillips, Director of Communications, press@smfm.org